Groups to Jointly Invest $8 Million in Ovarian Cancer Research Projects

Groups to Jointly Invest $8 Million in Ovarian Cancer Research Projects
To help find innovative ways to detect, treat, and prevent ovarian cancer, the Ovarian Cancer Research Alliance and the American Cancer Society plan to jointly invest $8 million in four multidisciplinary research projects, yet to be announced. The four-year initiative, which also seeks to prevent disease relapse and improve patients' quality of life, aims to raise funds to back investigators looking into biological, clinical, and psychosocial elements associated with ovarian cancer outcomes. After funding is secured, the research teams will be selected through a proposal and peer review process. ”More and more, scientists and organizations are recognizing the need to break down barriers and work together to find answers,” William Phelps, PhD, senior vice president of extramural research, American Cancer Society, said in a news release. “This approach is particularly important in ovarian cancer, a disease for which new innovative treatments are urgently needed.” The fifth-leading cause of cancer death among women, ovarian cancer causes more fatalities than any other cancer of the female reproductive system. According to the American Cancer Society, some 22,530 women in the United States will be diagnosed with the disease this year. Of them, 13,980 will die. A major issue is that upon diagnosis, four of five patients will already have advanced disease, a condition associated with higher risk of persistent and recurrent cancer following treatment. Currently, there is no way
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *